Cargando…

Unproven stem cell therapy for macular degeneration

Detalles Bibliográficos
Autores principales:	Ansari, Zubair A., Kuriyan, Ajay E., Albini, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710873/ https://www.ncbi.nlm.nih.gov/pubmed/29207592 http://dx.doi.org/10.18632/oncotarget.21891

Ejemplares similares

Unproven medical devices and cancer therapy: big claims but no evidence
por: Mac Manus, MP
Publicado: (2008)

Threat posed by unproven drugs in medical oncology
por: Pondé, Noam, et al.
Publicado: (2016)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
por: McLean, Alison K, et al.
Publicado: (2015)

Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
por: McLean, Alison K, et al.
Publicado: (2015)

Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices
por: Prasad, Vinay, et al.
Publicado: (2014)

Erratum to: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
por: McLean, Alison K., et al.
Publicado: (2016)

Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions
por: Ogbogu, Ubaka, et al.
Publicado: (2018)

Designing persuasive health education for patients seeking unproven stem cell interventions
por: Kawam, Omar, et al.
Publicado: (2023)

Age Macular Degeneration: Etiology, Prevention, Individualized Therapies, Cell Therapy, and Tissue Engineering
por: García-Layana, Alfredo, et al.
Publicado: (2014)

Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions
por: Horner, Claire, et al.
Publicado: (2018)

Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action
por: Caulfield, Timothy, et al.
Publicado: (2019)

Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
por: Li, Hong-tian, et al.
Publicado: (2020)

Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
por: Li, Hong-tian, et al.
Publicado: (2020)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Trends of Stem Cell Therapies in Age-Related Macular Degeneration
por: Maeda, Tadao, et al.
Publicado: (2021)

Diesel engine exhaust and lung cancer: an unproven association.
por: Muscat, J E, et al.
Publicado: (1995)

Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders
por: Matthews, Kirstin R. W., et al.
Publicado: (2015)

How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments
por: Hawke, Bethany, et al.
Publicado: (2019)

Unproven stem cell interventions: A global public health problem requiring global deliberation
por: Master, Zubin, et al.
Publicado: (2021)

Age-Related Macular Degeneration and Diabetic Retinopathy
por: Ebneter, Andreas, et al.
Publicado: (2022)

Research Advances in Age-Related Macular Degeneration
por: Abdolrahimzadeh, Solmaz
Publicado: (2022)

Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous
por: Olmos, Rodrigo Diaz, et al.
Publicado: (2021)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020)

Our favorite unproven ideas for future critical care
por: Marini, John J, et al.
Publicado: (2013)

Endometrial Receptivity Analysis (ERA) test: an unproven technology
por: Ben Rafael, Zion
Publicado: (2021)

Remdesivir retreatment: another unproven intervention for COVID-19
por: Al-Heeti, Omar, et al.
Publicado: (2022)

Benefits of nirmatrelvir–ritonavir remain unproven for some populations
por: McDonald, Emily G., et al.
Publicado: (2022)

Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products
por: Dulak, Józef, et al.
Publicado: (2023)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
por: Manley, Haley, et al.
Publicado: (2022)

Stem cell therapies for age-related macular degeneration: the past, present, and future
por: Dang, Yalong, et al.
Publicado: (2015)

Alcohol, Excitotoxicity and Adult Brain Damage: An Experimentally Unproven Chain-of-Events
por: Collins, Michael A., et al.
Publicado: (2016)

Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008)

Thinking forward: promising but unproven ideas for future intensive care
por: Marini, John J., et al.
Publicado: (2019)

Scientific Papers and Patents on Substances with Unproven Effects. Part 2
por: Jargin, Sergei V.
Publicado: (2019)

Disseminated melioidosis in early pregnancy - an unproven cause of foetal loss
por: Chang, Chee Yik, et al.
Publicado: (2020)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ol5vld4uou8cuheid4987vf6o